Literature DB >> 24573384

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.

M Kontro1, H Kuusanmäki2, S Eldfors3, T Burmeister4, E I Andersson1, O Bruserud5, T H Brümmendorf6, H Edgren3, B T Gjertsen5, M Itälä-Remes7, S Lagström3, O Lohi8, T Lundán9, J M L Martí3, M M Majumder3, A Parsons3, T Pemovska3, H Rajala1, K Vettenranta10, O Kallioniemi3, S Mustjoki1, K Porkka1, C A Heckman11.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24573384     DOI: 10.1038/leu.2014.89

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

Review 2.  Naive T cell homeostasis: from awareness of space to a sense of place.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

3.  Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Authors:  Tea Pemovska; Mika Kontro; Bhagwan Yadav; Henrik Edgren; Samuli Eldfors; Agnieszka Szwajda; Henrikki Almusa; Maxim M Bespalov; Pekka Ellonen; Erkki Elonen; Bjørn T Gjertsen; Riikka Karjalainen; Evgeny Kulesskiy; Sonja Lagström; Anna Lehto; Maija Lepistö; Tuija Lundán; Muntasir Mamun Majumder; Jesus M Lopez Marti; Pirkko Mattila; Astrid Murumägi; Satu Mustjoki; Aino Palva; Alun Parsons; Tero Pirttinen; Maria E Rämet; Minna Suvela; Laura Turunen; Imre Västrik; Maija Wolf; Jonathan Knowles; Tero Aittokallio; Caroline A Heckman; Kimmo Porkka; Olli Kallioniemi; Krister Wennerberg
Journal:  Cancer Discov       Date:  2013-09-20       Impact factor: 39.397

Review 4.  IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.

Authors:  Daniel Ribeiro; Alice Melão; João T Barata
Journal:  Adv Biol Regul       Date:  2012-10-16

5.  Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis.

Authors:  K Yamada; K Ariyoshi; M Onishi; A Miyajima; F Hayakawa; M Towatari; H Saito; Y Oka; S Asano; T Nosaka; T Kitamura
Journal:  Int J Hematol       Date:  2000-01       Impact factor: 2.490

6.  Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Authors:  Priscila P Zenatti; Daniel Ribeiro; Wenqing Li; Linda Zuurbier; Milene C Silva; Maddalena Paganin; Julia Tritapoe; Julie A Hixon; André B Silveira; Bruno A Cardoso; Leonor M Sarmento; Nádia Correia; Maria L Toribio; Jörg Kobarg; Martin Horstmann; Rob Pieters; Silvia R Brandalise; Adolfo A Ferrando; Jules P Meijerink; Scott K Durum; J Andrés Yunes; João T Barata
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

7.  TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.

Authors:  Takaomi Sanda; Jeffrey W Tyner; Alejandro Gutierrez; Vu N Ngo; Jason Glover; Bill H Chang; Arla Yost; Wenxue Ma; Angela G Fleischman; Wenjun Zhou; Yandan Yang; Maria Kleppe; Yebin Ahn; Jessica Tatarek; Michelle A Kelliher; Donna S Neuberg; Ross L Levine; Richard Moriggl; Mathias Müller; Nathanael S Gray; Catriona H M Jamieson; Andrew P Weng; Louis M Staudt; Brian J Druker; A Thomas Look
Journal:  Cancer Discov       Date:  2013-03-07       Impact factor: 39.397

8.  Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Samuli Eldfors; Heikki Kuusanmäki; Arjan J van Adrichem; Thomas Olson; Sonja Lagström; Emma I Andersson; Andres Jerez; Michael J Clemente; Yiyi Yan; Dan Zhang; Andy Awwad; Pekka Ellonen; Olli Kallioniemi; Krister Wennerberg; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Caroline Heckman; Satu Mustjoki
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

9.  Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.

Authors:  Elisabetta Flex; Valentina Petrangeli; Lorenzo Stella; Sabina Chiaretti; Tekla Hornakova; Laurent Knoops; Cristina Ariola; Valentina Fodale; Emmanuelle Clappier; Francesca Paoloni; Simone Martinelli; Alessandra Fragale; Massimo Sanchez; Simona Tavolaro; Monica Messina; Giovanni Cazzaniga; Andrea Camera; Giovanni Pizzolo; Assunta Tornesello; Marco Vignetti; Angela Battistini; Hélène Cavé; Bruce D Gelb; Jean-Christophe Renauld; Andrea Biondi; Stefan N Constantinescu; Robin Foà; Marco Tartaglia
Journal:  J Exp Med       Date:  2008-03-24       Impact factor: 14.307

10.  Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.

Authors:  Joao T Barata; Ana Silva; Joana G Brandao; Lee M Nadler; Angelo A Cardoso; Vassiliki A Boussiotis
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more
  46 in total

Review 1.  Mature T-cell leukemias: Molecular and Clinical Aspects.

Authors:  Nathanael G Bailey; Kojo S J Elenitoba-Johnson
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

2.  High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

Authors:  Emma I Andersson; Takahiro Tanahashi; Nodoka Sekiguchi; Vanessa Rebecca Gasparini; Sabrina Bortoluzzi; Toru Kawakami; Kazuyuki Matsuda; Takeki Mitsui; Samuli Eldfors; Stefania Bortoluzzi; Alessandro Coppe; Andrea Binatti; Sonja Lagström; Pekka Ellonen; Noriyasu Fukushima; Sayaka Nishina; Noriko Senoo; Hitoshi Sakai; Hideyuki Nakazawa; Yok-Lam Kwong; Thomas P Loughran; Jaroslaw P Maciejewski; Satu Mustjoki; Fumihiro Ishida
Journal:  Blood       Date:  2016-10-03       Impact factor: 22.113

3.  The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse.

Authors:  Obul R Bandapalli; Stephanie Schuessele; Joachim B Kunz; Tobias Rausch; Adrian M Stütz; Noa Tal; Ifat Geron; Nava Gershman; Shai Izraeli; Juliane Eilers; Nina Vaezipour; Renate Kirschner-Schwabe; Jana Hof; Arend von Stackelberg; Martin Schrappe; Martin Stanulla; Martin Zimmermann; Rolf Koehler; Smadar Avigad; Rupert Handgretinger; Viktoras Frismantas; Jean Pierre Bourquin; Beat Bornhauser; Jan O Korbel; Martina U Muckenthaler; Andreas E Kulozik
Journal:  Haematologica       Date:  2014-06-27       Impact factor: 9.941

4.  The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Thomas Olson; Michael J Clemente; Sonja Lagström; Pekka Ellonen; Tuija Lundan; David E Hamm; Syed Arshi Uz Zaman; Jesus M Lopez Marti; Emma I Andersson; Andres Jerez; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Satu Mustjoki
Journal:  Haematologica       Date:  2014-10-03       Impact factor: 9.941

5.  Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.

Authors:  Marc R Mansour; Casie Reed; Amy R Eisenberg; Jen-Chieh Tseng; Jean-Claude Twizere; Sarah Daakour; Akinori Yoda; Scott J Rodig; Noa Tal; Chen Shochat; Alla Berezovskaya; Daniel J DeAngelo; Stephen E Sallan; David M Weinstock; Shai Izraeli; Andrew L Kung; Alex Kentsis; A Thomas Look
Journal:  Br J Haematol       Date:  2014-09-26       Impact factor: 6.998

Review 6.  The genetics and mechanisms of T cell acute lymphoblastic leukaemia.

Authors:  Laura Belver; Adolfo Ferrando
Journal:  Nat Rev Cancer       Date:  2016-07-25       Impact factor: 60.716

7.  Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea.

Authors:  Chi A Ma; Liqiang Xi; Brian Cauff; Adam DeZure; Alexandra F Freeman; Sophie Hambleton; Gary Kleiner; T Ronan Leahy; Maureen O'Sullivan; Michelle Makiya; Grainne O'Regan; Stefania Pittaluga; Julie Niemela; Jennifer Stoddard; Sergio D Rosenzweig; Mark Raffeld; Amy D Klion; Joshua D Milner
Journal:  Blood       Date:  2016-12-12       Impact factor: 22.113

Review 8.  JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications.

Authors:  Lorraine Springuel; Jean-Christophe Renauld; Laurent Knoops
Journal:  Haematologica       Date:  2015-10       Impact factor: 9.941

Review 9.  Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Authors:  Barbara Pro; Pamela Allen; Amir Behdad
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

Review 10.  Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

Authors:  Sarah D Cramer; Peter D Aplan; Scott K Durum
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.